Philippe Camus, M.D.

Dijon, France

Both apps are now back!

Back

The Drug-Induced Respiratory Disease Website and App

XLIX.t

XLIX - Systemic/Distant conditions, syndromes and reactions

Fluid retention

Last update 17/06/2026

May manifest with weight gain, tissue edema, cardiomegaly and electrlyte disturbances. See also under Xc

Causative drugs

11

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Abiraterone
I.a
I.b
XLI.b
XLIX.t
LI.a
LI.ak
Amphotericin B (infusion)
I.e
XLI.a
XLI.e
XLIII.a
XLIV.c
XLVI.e
XLIX.f
XLIX.i
XLIX.t
L.b
LI.u
LVIII.be
Arsenic trioxide (As2O3)
I.a
XLI.a
XLI.e
XLI.l
XLII.a
XLV.a
XLIX.t
XLIX.ad
LI.c
LI.ak
Dasatinib
I.a
I.e
I.o
I.z
XLI.a
XLV.a
XLV.c
XLV.d
XLV.h
XLV.i
XLV.m
XLVI.b
XLIX.d
XLIX.t
L.b
LI.c
LV.m
LV.ap
LVII.a
LVIII.d
LVIII.n
LVIII.bm
LVIII.bp
Docetaxel
I.a
I.b
I.g
XLI.a
XLI.d
XLI.e
XLII.a
XLV.a
XLIX.c
XLIX.i
XLIX.p
XLIX.t
LI.c
LI.u
LVIII.a
LVIII.o
LVIII.v
Glitazones
XLI.a
XLI.b
XLI.j
XLV.a
XLV.i
XLIX.t
LI.a
Gonadotropin
XLI.a
XLI.e
XLV.a
XLV.g
XLV.i
XLIX.f
XLIX.t
L.n
Hydrocortisone
XLI.a
XLIII.a
XLIII.b
XLIII.f
XLVIII.a
XLIX.f
XLIX.t
LI.x
Imatinib
I.a
I.b
I.c
I.e
I.n
I.o
I.z
XLI.b
XLI.e
XLII.a
XLV.a
XLV.c
XLV.i
XLV.m
XLV.ah
XLIX.a
XLIX.p
XLIX.t
LI.a
LI.c
LI.g
LVIII.a
LVIII.d
LVIII.n
LVIII.bp
LIX.g
LIX.h
LIX.o
LIX.v
LX.g
Interleukin 2 (IL2)
I.c
XLI.a
XLI.e
XLIII.a
XLV.a
XLIX.c
XLIX.m
XLIX.t
LI.a
LI.c
LI.d
LI.g
LI.h
LI.ak
Nilotinib
I.a
I.e
XLII.a
XLV.a
XLV.c
XLVI.b
XLVI.d
XLIX.t
LI.c
LI.l
LI.p
LI.bb
LVIII.bm